Skip to content
Strategic Partnering
News
Contact Us
Strategic Partnering
News
Contact Us
About Us
Our Mission
Leadership
Grants
Disease Areas
Topical Scarring & Burns
Organ Fibrosis
Autoimmune Disorders
Wrinkles & Rhytids
Our Science
FS2: Kynurenic Acid
AI-001: Antigen-Presenting Cells
University of British Columbia
Products & Pipeline
NHP / Cosmetics Platform
Clinical Program & Pipeline
About Us
Our Mission
Leadership
Grants
Disease Areas
Topical Scarring & Burns
Organ Fibrosis
Autoimmune Disorders
Wrinkles & Rhytids
Our Science
FS2: Kynurenic Acid
AI-001: Antigen-Presenting Cells
University of British Columbia
Products & Pipeline
NHP / Cosmetics Platform
Clinical Program & Pipeline
About Us
Our Mission
Leadership
Grants
Disease Areas
Topical Scarring & Burns
Organ Fibrosis
Autoimmune Disorders
Wrinkles & Rhytids
Our Science
FS2: Kynurenic Acid
AI-001: Antigen-Presenting Cells
University of British Columbia
Products & Pipeline
NHP / Cosmetics Platform
Clinical Program & Pipeline
Strategic Partnering
News
Contact Us
About Us
Our Mission
Leadership
Grants
Disease Areas
Topical Scarring & Burns
Organ Fibrosis
Autoimmune Disorders
Wrinkles & Rhytids
Our Science
FS2: Kynurenic Acid
AI-001: Antigen-Presenting Cells
University of British Columbia
Products & Pipeline
NHP / Cosmetics Platform
Clinical Program & Pipeline
Strategic Partnering
News
Contact Us
Chief Science Officer, Dr. Ryan Hartwell, Lecture at South Beach Symposium on the Latest Discoveries and Innovations in Fibrosis Research, Notably Highlighting Published Data from BirchBioMed and the University of British Columbia.
UBC_SouthBeach_Faculty-Presentation_Hartwellv2